Dosimetric effects of respiratory motion during stereotactic body radiation therapy of lung tumors

References

• Guckenberger M, Andratschke N, Alheit H, et al. Definition of stereotactic body radiotherapy - principles and practice for the treatment of stage I non-small cell lung cancer. Strahlenther Onkol. 2014;190(1):26–33.
   PubMed Web of Science ®Google Scholar
• Fakiris AJ, McGarry RC, Yiannoutsos CT, et al. Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: four-year results of a prospective phase II study. Int J Radiat Oncol Biol. Phys. 2009;75(3):677–682.
   PubMed Web of Science ®Google Scholar
• De Ruysscher D, Faivre-Finn C, Moeller D, et al. European organization for research and treatment of cancer (EORTC) recommendations for planning and delivery of high-dose, high precision radiotherapy for lung cancer. Radiother Oncol. 2017;124(1):1–10.
   PubMed Web of Science ®Google Scholar
• Zheng X, Schipper M, Kidwell K, et al. Survival outcome after stereotactic body radiation therapy and surgery for stage I non-small cell lung cancer: a metaanalysis. Int J Radiat Oncol Biol Phys. 2014;90(3):603–611.
   PubMed Web of Science ®Google Scholar
• Chang JY, Senan S, Paul MA, et al. Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials. Lancet Oncol. 2015;16(6):630–637.
   PubMed Web of Science ®Google Scholar
• Gomez DR, Blumenschein GR, Jr Lee JJ, et al. Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study. Lancet Oncol. 2016;17(12):1672–1682.
   PubMed Web of Science ®Google Scholar
• Nyman J, Hallqvist A, Lund JÅ, et al. SPACE – a randomized study of SBRT vs conventional fractionated radiotherapy in medically inoperable stage I NSCLC. Radiother Oncol. 2016;121(1):1–83.
   PubMed Web of Science ®Google Scholar
• Baumann P, Nyman J, Hoyer M, et al. Outcome in a prospective phase II trial of medically inoperable stage I non–small-cell lung cancer patients treated with stereotactic body radiotherapy. J Clin Oncol. 2009;27(20):3290–3296.
   PubMed Web of Science ®Google Scholar
• Vansteenkiste J, Ruysscher DD, Eberhardt WEE, et al. Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013;24(suppl_6):vi89–vi98.
   PubMed Web of Science ®Google Scholar
• Lindberg K, Grozman V, Karlsson K, et al. The HILUS-Trial—a prospective nordic multicenter phase 2 study of ultracentral lung tumors treated with stereotactic body radiotherapy. J Thorac Oncol. 2021;16(7):1200–1210.
   PubMed Web of Science ®Google Scholar
• Court L, Wagar M, Berbeco R, et al. Evaluation of the interplay effect when using RapidArc to treat targets moving in the craniocaudal or right‐left direction. Med Phys. 2009;37(1):4–11.
   Web of Science ®Google Scholar
• Li X, Yang Y, Li T, et al. Dosimetric effect of respiratory motion on volumetric‐modulated arc therapy‐based lung SBRT treatment delivered by TrueBeam machine with flattening filter‐free beam. J Appl Clin Med Phys. 2013;14(6):4370–4204.
   PubMed Web of Science ®Google Scholar
• Ong C, Dahele M, Slotman BJ, et al. Dosimetric impact of the interplay effect during stereotactic lung radiation therapy delivery using flattening filter-free beams and volumetric modulated arc therapy. Int J Radiat Oncol Biol Phys. 2013;86(4):743–748.
   PubMed Web of Science ®Google Scholar
• Ceberg S, Ceberg C, Falk M, et al. Evaluation of breathing interplay effects during VMAT by using 3D gel measurements. in Journal of Physics: Conference Series. 2013. IOP Publishing.
   Google Scholar
• Rao M, Wu J, Cao D, et al. Dosimetric impact of breathing motion in lung stereotactic body radiotherapy treatment using image-modulated radiotherapy and volumetric modulated arc therapy. Int J Radiat Oncol Biol Phys. 2012;83(2):e251–e256.
   PubMed Web of Science ®Google Scholar
• Schmidt ML, Hoffmann L, Kandi M, et al. Dosimetric impact of respiratory motion, interfraction baseline shifts, and anatomical changes in radiotherapy of non-small cell lung cancer. Acta Oncol. 2013;52(7):1490–1496.
   PubMed Web of Science ®Google Scholar
• Ong C, Verbakel WFAR, Cuijpers JP, et al. Dosimetric impact of interplay effect on RapidArc lung stereotactic treatment delivery. Int J Radiat Oncol Biol Phys. 2011;79(1):305–311.
   PubMed Web of Science ®Google Scholar
• Keall PJ, Mageras GS, Balter JM, et al. The management of respiratory motion in radiation oncology report of AAPM task group 76 a. Med Phys. 2006;33(10):3874–3900.
   PubMed Web of Science ®Google Scholar
• Sarudis S, Karlsson Hauer A, Nyman J, et al. Systematic evaluation of lung tumor motion using four-dimensional computed tomography. Acta Oncol. 2017;56(4):525–530.
   PubMed Web of Science ®Google Scholar
• Duan J, Shen S, Fiveash JB, et al. Dosimetric and radiobiological impact of dose fractionation on respiratory motion induced IMRT delivery errors: a volumetric dose measurement study. Med Phys. 2006;33(5):1380–1387.
   PubMed Web of Science ®Google Scholar
• Schaefer M, Münter MW, Thilmann C, et al. Influence of intra-fractional breathing movement in step-and-shoot IMRT. Phys Med Biol. 2004;49(12):N175–N179.
   PubMed Web of Science ®Google Scholar
• Seco J, Sharp GC, Turcotte J, et al. Effects of organ motion on IMRT treatments with segments of few monitor units. Med Phys. 2007;34(3):923–934.
   PubMed Web of Science ®Google Scholar
• Edvardsson A, Nordström F, Ceberg C, et al. Motion induced interplay effects for VMAT radiotherapy. Phys Med Biol. 2018;63(8):085012.
   PubMed Web of Science ®Google Scholar
• Archibald‐Heeren BR, Byrne MV, Hu Y, et al. Robust optimization of VMAT for lung cancer: dosimetric implications of motion compensation techniques. J Appl Clin Med Phys. 2017;18(5):104–116.
   PubMed Web of Science ®Google Scholar
• Gauer T, Sothmann T, Blanck O, et al. Under-reported dosimetry errors due to interplay effects during VMAT dose delivery in extreme hypofractionated stereotactic radiotherapy. Strahlenther Onkol. 2018;194(6):570–579.
   PubMed Web of Science ®Google Scholar
• Ogrinc G, Davies L, Goodman D, et al. SQUIRE 2.0 (standards for quality improvement reporting excellence): revised publication guidelines from a detailed consensus process. BMJ Qual Saf. 2016;25(12):986–992.
   PubMed Web of Science ®Google Scholar
• Weistrand O, Svensson S. The ANACONDA algorithm for deformable image registration in radiotherapy. Med Phys. 2015;42(1):40–53.
   PubMed Web of Science ®Google Scholar
• Kadoya N, Nakajima Y, Saito M, et al. Multi-institutional validation study of commercially available deformable image registration software for thoracic images. Int J Radiat Oncol Biol Phys. 2016;96(2):422–431.
   PubMed Web of Science ®Google Scholar
• Götstedt J, Karlsson Hauer A, Bäck A. Development and evaluation of aperture-based complexity metrics using film and EPID measurements of static MLC openings. Med Phys. 2015;42(7):3911–3921.
   PubMed Web of Science ®Google Scholar
• Götstedt J, Bäck A. Edge area metric complexity scoring of volumetric modulated arc therapy plans. Phys Imaging Radiat Oncol. 2021;17:124–129.
   PubMedGoogle Scholar
• Guckenberger M, Belka C, Bezjak A, et al. Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: an ESTRO-ASTRO consensus statement. Radiother Oncol. 2020;146:223–229.
   PubMed Web of Science ®Google Scholar
• Ng SSW, Ning MS, Lee P, et al. Single-Fraction stereotactic body radiation therapy: a paradigm during the coronavirus disease 2019 (COVID-19) pandemic and beyond? Adv Radiat Oncol. 2020;5(4):761–773.
   PubMedGoogle Scholar
• Riley C, Yang Y, Li T. Dosimetric evaluation of the interplay effect in respiratory-gated RapidArc radiation therapy. Med Phys. 2014;41:11715.
   Web of Science ®Google Scholar
• Ehrbar S, Lang S, Stieb S, et al. Three-dimensional versus four-dimensional dose calculation for volumetric modulated arc therapy of hypofractionated treatments. Z Med Phys. 2016;26(1):45–53.
   PubMed Web of Science ®Google Scholar
• Seppenwoolde Y, Shirato H, Kitamura K, et al. Precise and real-time measurement of 3D tumor motion in lung due to breathing and heartbeat, measured during radiotherapy. Int J Radiat Oncol Biol Phys. 2002;53(4):822–834.
   PubMed Web of Science ®Google Scholar